Yuri Vasconcelos
Overview
Explore the profile of Yuri Vasconcelos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
101
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodrigues C, Vescovi Goncalves M, Ikoma M, Lorand-Metze I, Pereira A, de Farias D, et al.
Rev Bras Hematol Hemoter
. 2017 Mar;
39(1):93-94.
PMID: 28270360
No abstract available.
2.
Rodrigues C, Vescovi Goncalves M, Ikoma M, Lorand-Metze I, Pereira A, de Farias D, et al.
Rev Bras Hematol Hemoter
. 2016 Nov;
38(4):346-357.
PMID: 27863764
Chronic lymphocytic leukemia is characterized by clonal proliferation and progressive accumulation of B-cell lymphocytes that typically express CD19, CD5 and CD23. The lymphocytes usually infiltrate the bone marrow, peripheral blood,...
3.
Oppezzo P, Vasconcelos Y, Settegrana C, Jeannel D, Vuillier F, Legarff-Tavernier M, et al.
Blood
. 2005 Apr;
106(2):650-7.
PMID: 15802535
Although the zeta-associated protein of 70 kDa (ZAP-70) is overexpressed in patients with chronic lymphocytic leukemia (CLL) displaying unmutated IGVH genes and poor prognosis, a previous microarray study from our...
4.
Vasconcelos Y, Davi F, Levy V, Oppezzo P, Magnac C, Michel A, et al.
J Clin Oncol
. 2003 Oct;
21(21):3928-32.
PMID: 14581416
Purpose: Rai's and Binet's staging systems have contributed significantly to the identification of major prognostic groups in chronic lymphocytic leukemia (CLL), though they fail to accurately predict disease progression at...
5.
Oppezzo P, Vuillier F, Vasconcelos Y, Dumas G, Magnac C, Payelle-Brogard B, et al.
Blood
. 2003 Jan;
101(10):4029-32.
PMID: 12521993
In B cells, somatic hypermutation (SHM) and class switch recombination (CSR) depend on the activation-induced cytidine deaminase (AID) gene product, although the precise mode of action of AID remains unknown....